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1. Introduction 
Little is known so far on the mechanisms involved 
in the autonomous hyperfunction of thyroid toxic 
adenomas (TA). Because of its importance in cell 
growth, differentiation a d function, the activity of 
the adenylate cyclase-cyclic AMP-protein kinase 
system has been investigated in TA. However, while 
the adenylate cyclase activity has been found generally 
hyperactive and hyperresponsive to TSH [ 1-3 ], no 
consistent pattern has been observed for the protein 
kinase activity [4]. We report here evidence for an 
elevated cyclic AMP (cAMP)-independent protein 
kinase activity (PICA) in the cytosols from TA as com- 
pared to normal thyroid tissue (N). 
2. Material and methods 
2.1. Patients 
Samples of thyroid tissue were obtained at surgery 
from 8 patients operated on for a TA. None of these 
patients had received antithyroid rugs prior to 
surgery. Diagnosis of TA had been assured by a thyroid 
scintiscan showing radioactivity only in the nodule 
area. Each patient showed some degree of clinical 
hyperthyroidism. For comparison, samples of normal 
thyroid tissue (N) were obtained from 8 euthyroid 
patients operated on for a cold nodule. These samples 
showed no gross macroscopic abnormality and were 
later confirmed to be normal by histological examina- 
tion. Plasma T4 and T3 resin uptake were 7.1 +- 0.6 
#g/dl and 25.4 -+ 0.4% in the euthyroid and 12.1 -+ 1.9 
/~g/dl and 33.3 -+ 2.6%, in the TA patients (p<0.05). 
Plasma T3 was 132 -+ 7 ng/dl in the euthyroid and 
235 --- 56 ng/dl in the 3 hyperthyroid patients o 
tested (p<0.05). 
2.2. Tissue preparation 
Fresh thyroid samples were sliced at 0-4°C using 
a Stadie Riggs microtome. The slices were washed, 3
times in 10 min, in 5 mM phosphate, 2 mM EDTA 
buffer (pH 7.0), then in 0.25 M sucrose, 20 mM Tris- 
HCI, pH 7.4, (Tris sucrose) in which they were 
homogeneized first in 3 vol./wt tissue with a Waring 
Blender (high speed, 4 periods of 30 s) and then 
further with an all glass motor-driven homogeneizer. 
The homogenates were filtered through 4 layers of 
gauze and centrifuged at 105 000 X g for 1 h. The 
pellets were washed twice in 5 ml Tris-sucrose, cen- 
trifuged at 105 000 X g for 2 h and finally resuspended 
in 4 ml 50 mM Tris-HC1, pH 7.2. The 105 000 X g 
supernatants and the washed pellets were stored in 
aliquots at -20°C until use. 
2.3. Protein kinase activity 
PKA was assayed in 25/al aliquots of soluble and 
particulate material as in [5] in the presence of 50/ag 
histone IIA (Sigma), 0.7 X 10 -s M or, in some experi- 
ments varying amounts of non radioactive ATP ranging 
from 10-6-10 -s M and 5 X l0 s cpm of [~,-32P]ATP 
(0.5-3.0 Ci/mmol; Amersham), without or with 
various doses of cAMP, in final vol. 225 bd. Preliminary 
experiments had shown that in these conditions the 
PKA of the soluble and particulate fractions from 
both TA and N tissues was linear for amounts of 
protein up to 50 ttg/tube and for more than 20 rain 
incubation. NaF, 10 mM was added only for the assay 
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of the particulate material. Blank values determined 
in the presence of 50/ag bovine serum albumine (BSA) 
instead of histone were subtracted from the experi- 
mental values. Blank values were not different in TA 
and N and amounted to less than 10% experimental 
activity. 
The cAMP-dependent protein kinase heat-stable 
inhibitor was purified from 250 g rat brain as in [6]. 
The amount of inhibitor to be used in the assay was 
determined in preliminary dose-effect experiments 
on basal as well as maximally cAMP-stimulated PKA 
of various thyroid tissues. While an average basal PKA 
of 4 pmol phosphorus (P) transferred to histone per 
10 min was maximally inhibited by 6/ag inhibitor/ 
tube, 26/ag were necessary to abolish the 2-4-fold 
PKA stimulation elicited by 10 -s M cAMP. Therefore, 
we routinely used 26/ag inhibitor/assay tube in all 
experiments. 
2.4. Assays 
DNA assay was performed as in [7] modified [8] 
with calf thymus DNA (Sigma) as the standard. The 
DNA content was 1.53 +- 0.22/ag/mg and 1.14 + 0.08 
tag/mg tissue (wet wt) for N and TA, respectively, a 
difference not significant. The protein content of 
the cytosols, expressed per 100 mg wet wt, was 
3.37 -+ 0.17 mg and 2.08 +-- 0.17 mg and that of the 
particulate fraction 2.03 + 0.33 mg and 2.27 + 0.11 
mg for N and TA, respectively, as determined [9] 
with BSA standard. These differences were not sig- 
nificant. The cAMP concentration was assayed in 
thyroid cytosols after 0.3 M perchloric acid precipi- 
tation and purification through a Biorad AG 50 
W X 4 column eluted with 0.1 N HC1. The fractions 
containing the cAMP were pooled, lyophilized and 
assayed as in [10]. The recovery of the extraction 
was 95-99% (10 expts). The cAMP concentrations in 
cytosols from N and TA tissues were 7.7 -+ 1.1 pmol/ 
mg DNA and 9.9 -+ 2.8 pmol/mg DNA, respectively. 
This difference was not significant. 
3. Results 
In TA, basal soluble PKA was twice as high as in N 
(table 1). This was observed whether PKA was ex- 
pressed per/ag DNA (table 1) or per mg proteins 
(TA = 249 +- 30;N = 108 + 18 pmol P transferred• 
10 min;p<0.01). In the presence of 10 -s M cAMP 
the PKA was also significantly greater in TA than in 
N, although the difference was less marked than for 
the basal activity. Therefore, the percent increase over 
basal elicited by 10 -s M cAMP was within normal 
limits. It is of interest o note that in both types of 
tissues half maximal activation of  PKA occurred at 
similar concentration of cAMP, approx. 10 -7 M. 
Basal PKA was also measured in another experiment, 
in the presence of varying amounts of ATP (table 2). 
The difference between TA and N was observed up to 
a maximal concentration ATP (10 -3 M). In contrast, 
Table 1 
Soluble and particulate PKAs in extracts from TA and N thyroid tissues 
Cytosol Particulate fraction 
Basal cAMP I0 -s M B Basal cAMP I0 -s M B 
(A) (B) A (A) (B) 
TA (8) 4.43 a 7.88 1.82 0.48 0.69 1.54 
-+ 0.37 -+ 0.44 -+ 0.09 +- 0.12 +- 0.12 -+ 0.17 
N (8) 2.26 5.36 2.42 0.44 0.66 1.46 
-+ 0.33 -+ 0.76 +- 0.26 + 0.II + 0.18 + 0.12 
P < 0.001 < 0.02 n.s. n.s. n.s. n.s. 
a Mean -+ SE : average of values obtained in 2 different experiments performed at 
several months interval 
PKA is expressed as pmol P transferred to histone/t~g DNA/10 min incubation 
( ) no. cytosols tested 
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Table 2 
Measurement ofbasal eytosolic PKA in the presence of increasing amounts of ATP 
ATP 
10-6M 10 -5 M 10 -4 M 10 -s M 
TA (4) 0.63 -+ 0.16 a 4.21 ± 0.8 13.25 ± 3.07 16.81 + 3.83 
N (6) 0.50 ± 0.05 2.39 ± 0.21 5.59 ± 0.64 7.10 ± 1.66 
P n.s. < 0.05 < 0.02 < 0.05 
a Mean ± SE of PKA (pmol P transferred//~g DNA/10 min) 
( ) no. cytosols tested 
in the particulate fraction obtained from TA, both 
basal and stimulated PKA expressed per/ag DNA, were 
normal. When expressed per mg particulate proteins, 
they were slightly subnormal, although not signifi- 
cantly (TA = 20.8 -+ 3.8; N = 31.3 -+ 6.4 pmol P trans- 
ferred/10 min). Similarly, the stimulability ratio was 
normal in the particulate fraction. 
In order to study further the abnormality of  PKA 
in TA, the soluble enzyme activity from N and TA 
was assayed in the presence of  cAMP dependent PKA 
inhibitor. Results are shown in table 3. The inhibitor 
suppressed an activity amounting to 1.1 and to 0.59 
pmol P transferred//~g DNA/10 min in TA and N, res- 
pectively. This represented a decrease of about 30% 
for both. In both kinds of tissue extracts, the inhibitor 
completely antagonized the effect of 10 -s M cAMP 
showing the effectiveness of this dose of inhibitor to 
be sufficient. Despite this potency of the inhibitor, 
the remaining basal PKA in TA was more than twice 
the normal value (p<0.01). Although the results 
shown in table 2 might indicate a slight increase of  
the basal cAMP-dependent PKA in TA, they clearly 
show a marked increase of the PKA was not suppressed 
by the inhibitor. Therefore, assuming that residual 
PKA in the presence of inhibitor is cAMP independent, 
one can conclude that the soluble cAMP-independent 
PKA is clearly supranormal in TA. 
4. Discussion 
Our data indicate agreater soluble PKA in TA than 
in N. This difference was observed repeatedly in 3 
different assays performed several months apart on 
frozen aliquots of each thyroid cytosol. This suggests 
that storage in the frozen state at -20°C did not 
Table 3 
Effect of the heat-stable protein kinase inhibitor on basal and 
stimulated eytosolie PKA 
No inhibitor Plus inhibitor (26 t~g/tube) 
No cAMP cAMP 10 -s M No cAMP cAMP 10 -s M 
TA (8) 4.27 ± 0.41 a 9.27 ± 0.63 3.17 ± 0.45 3.89 + 0.46 
N (8) 1.97 ± 0.19 5.60 ± 0.66 1.38 ± 0.14 1.67 + 0.15 
P < 0.001 < 0.01 < 0.01 < 0.001 
a Mean ± SE ofPKA (pmol P transferred/#g DNA/10 min) 
( ) Number of cytosols tested 
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affect the PKA significantly. The difference in PKA 
between TA and N was observed at low as well as 
high ATP concentration. Moreover, the ATP concen- 
tration giving half-maximal PKA was similar in both 
types of thyroid tissue. The difference in PKA was 
more marked in the absence than in the presence of 
maximal cAMP concentration, sothat the cAMP 
stimulation ratio tended to be lower, although not 
significantly, in TA than in N. Such a difference 
could be explained by a higher cAMP content of the 
TA cytosols. However, it is very unlikely that the 
small and not significant cAMP increase observed in the 
TA cytosols could account for it. Therefore, our results 
strongly suggest the presence in the thyroid cells from 
TA of an increased soluble PICA. The observation of a 
normal stimulability ratio by cAMP in TA seemed to 
indicate that the increased PKA was not due to an 
augmentation of the cAMP-dependent PKA. How- 
ever, in order to elucidate further this point, we 
studied the soluble PKA in the presence of the 
thermostable cAMP-dependent inhibitor. The inhib- 
itor did not abolish the difference between PKA from 
N and TA. Furthermore, in other experiments (manu- 
script in preparation) we also observe anormal 
capacity and affinity of  the cAMP-binding activity in 
TA as measured by equilibrium dialysis. These obser- 
vations suggest that in cytosols from TA the cAMP- 
dependent PKA was normal and that the extra PKA 
was mainly of the cAMP-independent type. It is inter- 
esting to note that the abnormality was restricted to 
the soluble enzyme, since the particulate activity was 
normal. 
The mode of expression of  soluble enzyme activi- 
ties in the thyroid is a sensitive point. Since thyro- 
globulin is the major soluble protein, referring to the 
amount of protein could be misleading. For this reason, 
results were expressed per unit of DNA. However, 
whatever the mode of expression, the results were 
similar. Indeed, we have found no difference in the 
DNA content expressed on a wet weight basis between 
N and TA. This is in keeping with a recent report in 
which no systematic alteration of  the cellular/colloid 
ratio was observed in TA [4]. 
The presence in the thyroid tissue of both cAMP- 
dependent and -independent PKAs has been docu- 
mented [11-13] .  An increased activity of both 
enzymes after chronic treatment of  rats by TSH was 
reported [13]. It is interesting to note that in TA, 
despite the low levels of circulating TSH, only the 
cAMP-independent PKA was clearly elevated. Since 
the respective involvement of the cAMP-dependent 
and -independent protein kinases in the thyroid 
function regulation processes i still poorly under- 
stood, the significance of this finding is not clear. It 
should be mentioned that in contrast o the present 
observation i TA, we reported on the absence of 
abnormality of the PKA in Graves' disease thyroid 
tissue [5]. 
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